Background Liddle＇s syndrome is a rare autosomal-dominant monogenic form of salt-sensitive hypertension. This study aimed to screen the gene mutation in 13 and y subunits of the epithelial sodium channel （ENaC） of ...Background Liddle＇s syndrome is a rare autosomal-dominant monogenic form of salt-sensitive hypertension. This study aimed to screen the gene mutation in 13 and y subunits of the epithelial sodium channel （ENaC） of a Chinese family with Liddle＇s syndrome, an autosomal dominant form of hypertension. Methods DNA samples from the proband with early-onset, treatment-resistant hypertension and suppressed plasma renin activity were initially screened for mutations in the C-terminal exons of the ENaC 13 or y subunit genes, using amplification by polymerase chain reaction and direct DNA sequencing. We also screened the C-terminus of SCNNIB and SCNNIG in family members, and screened for the mutation in 150 controls. Results Genetic analysis of the 13 ENaC gene revealed a missense mutation of CCC to TCC at codon 616 in the proband, her mother and her grandmother. One hundred and fifty randomly selected controls had not the mutation, indicating that this is not a common genetic polymorphism. There was no mutation of the y ENaC gene in any of the individuals examined. Conclusions Through direct DNA sequencing analysis, we established the diagnosis of Liddle＇s syndrome for the proband and her families, and provided tailored therapies to this abnormality. These results provide further evidence that Pro616Ser is a critical amino acid that has a key role in the inhibition of sodium channel activity.展开更多
文摘Background Liddle＇s syndrome is a rare autosomal-dominant monogenic form of salt-sensitive hypertension. This study aimed to screen the gene mutation in 13 and y subunits of the epithelial sodium channel （ENaC） of a Chinese family with Liddle＇s syndrome, an autosomal dominant form of hypertension. Methods DNA samples from the proband with early-onset, treatment-resistant hypertension and suppressed plasma renin activity were initially screened for mutations in the C-terminal exons of the ENaC 13 or y subunit genes, using amplification by polymerase chain reaction and direct DNA sequencing. We also screened the C-terminus of SCNNIB and SCNNIG in family members, and screened for the mutation in 150 controls. Results Genetic analysis of the 13 ENaC gene revealed a missense mutation of CCC to TCC at codon 616 in the proband, her mother and her grandmother. One hundred and fifty randomly selected controls had not the mutation, indicating that this is not a common genetic polymorphism. There was no mutation of the y ENaC gene in any of the individuals examined. Conclusions Through direct DNA sequencing analysis, we established the diagnosis of Liddle＇s syndrome for the proband and her families, and provided tailored therapies to this abnormality. These results provide further evidence that Pro616Ser is a critical amino acid that has a key role in the inhibition of sodium channel activity.
